SAN ANTONIO (AP) - In a Dec. 9 story about Novartis AG’s Reclast drug, The Associated Press erroneously described it as a twice-a-year treatment for osteoporosis. Reclast is given as an infusion once every two years for preventing osteoporosis in older women, and once a year to treat the disease.
sign up for
MOST READ ON WT
Classical music and the performing arts: news and reviews you can use.
Brazen, leading-edge, “call it like it is” columns and reporting from Ohio native, radio host and writer, Sara Marie Brenner.
Our Choice: Individual responsibility and self-government or the abandonment of the American Revolution
Al Maurer provides a common sense, conservatarian, Constitutional conservative perspective from the battleground state of Colorado